1. Home
  2. EVI vs DSGN Comparison

EVI vs DSGN Comparison

Compare EVI & DSGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EVI
  • DSGN
  • Stock Information
  • Founded
  • EVI 1959
  • DSGN 2017
  • Country
  • EVI United States
  • DSGN United States
  • Employees
  • EVI N/A
  • DSGN N/A
  • Industry
  • EVI Other Consumer Services
  • DSGN Biotechnology: Pharmaceutical Preparations
  • Sector
  • EVI Consumer Discretionary
  • DSGN Health Care
  • Exchange
  • EVI Nasdaq
  • DSGN Nasdaq
  • Market Cap
  • EVI 198.5M
  • DSGN 224.8M
  • IPO Year
  • EVI N/A
  • DSGN 2021
  • Fundamental
  • Price
  • EVI $16.30
  • DSGN $3.50
  • Analyst Decision
  • EVI
  • DSGN Hold
  • Analyst Count
  • EVI 0
  • DSGN 1
  • Target Price
  • EVI N/A
  • DSGN $4.00
  • AVG Volume (30 Days)
  • EVI 9.2K
  • DSGN 140.5K
  • Earning Date
  • EVI 05-20-2025
  • DSGN 05-07-2025
  • Dividend Yield
  • EVI 1.89%
  • DSGN N/A
  • EPS Growth
  • EVI 0.45
  • DSGN N/A
  • EPS
  • EVI 0.49
  • DSGN N/A
  • Revenue
  • EVI $360,461,000.00
  • DSGN N/A
  • Revenue This Year
  • EVI N/A
  • DSGN N/A
  • Revenue Next Year
  • EVI N/A
  • DSGN N/A
  • P/E Ratio
  • EVI $33.48
  • DSGN N/A
  • Revenue Growth
  • EVI N/A
  • DSGN N/A
  • 52 Week Low
  • EVI $14.51
  • DSGN $2.60
  • 52 Week High
  • EVI $22.48
  • DSGN $7.77
  • Technical
  • Relative Strength Index (RSI)
  • EVI 45.14
  • DSGN 42.85
  • Support Level
  • EVI $15.76
  • DSGN $3.23
  • Resistance Level
  • EVI $17.09
  • DSGN $5.04
  • Average True Range (ATR)
  • EVI 0.87
  • DSGN 0.48
  • MACD
  • EVI 0.03
  • DSGN -0.05
  • Stochastic Oscillator
  • EVI 48.52
  • DSGN 15.06

About EVI EVI Industries Inc.

EVI Industries Inc through its subsidiaries, is a distributor that sells, leases, and rents commercial, industrial, and vended laundry and dry cleaning equipment and steam and hot water boilers manufactured by others, supplies related replacement parts and accessories, designs and plans turn-key laundry, dry cleaning, and boiler systems, and provides installation and maintenance services to its customers, which include commercial, industrial, institutional, government, and retail customers. These activities are conducted in the United States, Canada, the Caribbean, and Latin America.

About DSGN Design Therapeutics Inc.

Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.

Share on Social Networks: